ISSN: 0963-6048
Journal Home
Journal Guideline
International Journal of Biotechnology Q4 Unclaimed
International Journal of Biotechnology is a journal indexed in SJR in Bioengineering and Management of Technology and Innovation with an H index of 22. It has an SJR impact factor of 0,106 and it has a best quartile of Q4. It is published in English. It has an SJR impact factor of 0,106.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy:
Type of publications:
Publication frecuency: -
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,106
SJR Impact factor22
H Index0
Total Docs (Last Year)5
Total Docs (3 years)0
Total Refs0
Total Cites (3 years)5
Citable Docs (3 years)0
Cites/Doc (2 years)0.0
Ref/DocOther journals with similar parameters
RSC Detection Science Q4
Acta of Bioengineering and Biomechanics Q4
Open Biomedical Engineering Journal Q4
Biomedical Engineering - Applications, Basis and Communications Q4
Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering Q4
Compare this journals
Aims and Scope
Best articles by citations
Biotechnology: legal and other issues in a Thailand experience
View moreMastering biological industrialisation: a social challenge
View moreInternational markets for genetic resources: opportunities for Colombia
View moreDevelopment and characterisation of sodium alginate and HPMC films for mucosal drug delivery
View moreUniversity and small biotechnology firms linkage: the evidence from Brazil
View moreRationalising fixed dose combinations for tuberculosis and acquired immunodeficiency syndrome therapy
View moreFrom principle to action: applying the precautionary principle to agricultural biotechnology
View moreManaging agricultural biotechnology for sustainable development: the case of semi-arid India
View moreManpower requirements in biotechnology and strategies to achieve them - international and Indian experiences
View moreThe process of value building in science-based companies: Geron and the 'Telome-race'
View moreNegotiating the precautionary principle: regulatory and institutional roots of divergent US and EU positions
View moreIntersection of toxicogenomics and high throughput screening in the Tox21 program: an NIEHS perspective
View moreA situation of multilateral co-operation: the ''couple hote-vecteur performant'' program (CHVP)
View moreThe social construction of an organisational field: the case of biotechnology
View moreBlazing the trail from stem cell research to regenerative medicine
View moreInnovating through networks: a case study in plant biotechnology
View moreRising to the technological challenge: possibilities for integration of biotechnology in the Indian pharmaceutical industry
View more'Coaching' small biotech companies into success
View moreAssessing the precautionary principle in the regulation of genetically modified organisms
View moreHow biotechnology is changing the structure of the seed industry
View moreUnsound science? Transatlantic regulatory disputes over GM crops
View moreThe evolution of biotechnology in bioregions and their globalisation
View moreWaste activated sludge reduction using sonication and cryptic growth
View moreAcceptance of modern biotechnology in developing countries: a case study of the Philippines
View more
Comments